Global and Japan Human Organs-on-Chip Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global and Japan Human Organs-on-Chip Market Report & Forecast 2024-2034
Market Analysis and InsightsGlobal and Japan Human Organs-on-Chip Market
This report focuses on global and Japan Human Organs-on-Chip market, also covers the segmentation data of other regions in regional level and county level.
The global Human Organs-on-Chip revenue was at US$ 87.87 million in the year 2023, is projected to reach a revised size of US$ 621.29 million by 2033, growing at a CAGR of 31.21% during the forecast period 2023-2033.
In Japan the Human Organs-on-Chip revenue is expected to grow from US$ 6.63 million in 2023 to US$ 58.68 million by 2033, at a CAGR of 34.78% during the forecast period (2023-2033).
The global key players of Human Organs-on-Chip include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, and Micronit Microtechnologies B.V., etc. The global five biggest players hold a share of 58.32% in 2023.
Global Human Organs-on-Chip Scope and Market Size
Human Organs-on-Chip market is segmented in regional and country level, by players, by Type, and by End User. Players, stakeholders, and other participants in the global Human Organs-on-Chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End User for the period 2018-2033.
For Japan market, this report focuses on the Human Organs-on-Chip market size by players, by Type, and by End User, for the period 2018-2033. The key players include the global and local players which play important roles in Japan.
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Human Organs-on-Chip definition, global market size, Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Human Organs-on-Chip companies competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue of Human Organs-on-Chip in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by Type, by End User and by country, revenue for each segment.
Chapter 7EMEA by Type, by End User and by region, revenue for each segment.
Chapter 8China by Type, and by End User, revenue for each segment.
Chapter 9APAC (excluding China) by Type, by End User and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Organs-on-Chiprevenue, gross margin, and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
This report focuses on global and Japan Human Organs-on-Chip market, also covers the segmentation data of other regions in regional level and county level.
The global Human Organs-on-Chip revenue was at US$ 87.87 million in the year 2023, is projected to reach a revised size of US$ 621.29 million by 2033, growing at a CAGR of 31.21% during the forecast period 2023-2033.
In Japan the Human Organs-on-Chip revenue is expected to grow from US$ 6.63 million in 2023 to US$ 58.68 million by 2033, at a CAGR of 34.78% during the forecast period (2023-2033).
The global key players of Human Organs-on-Chip include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, and Micronit Microtechnologies B.V., etc. The global five biggest players hold a share of 58.32% in 2023.
Global Human Organs-on-Chip Scope and Market Size
Human Organs-on-Chip market is segmented in regional and country level, by players, by Type, and by End User. Players, stakeholders, and other participants in the global Human Organs-on-Chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End User for the period 2018-2033.
For Japan market, this report focuses on the Human Organs-on-Chip market size by players, by Type, and by End User, for the period 2018-2033. The key players include the global and local players which play important roles in Japan.
By Company
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Human Organs-on-Chip definition, global market size, Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Human Organs-on-Chip companies competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue of Human Organs-on-Chip in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by Type, by End User and by country, revenue for each segment.
Chapter 7EMEA by Type, by End User and by region, revenue for each segment.
Chapter 8China by Type, and by End User, revenue for each segment.
Chapter 9APAC (excluding China) by Type, by End User and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Organs-on-Chiprevenue, gross margin, and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions